Designing and advancing the future of neurovascular care through clinical excellence, patient-centred care, and innovative research to reduce disability and extend life.
A simple, patient-centred way to measure recovery after treatment.
DAH30 is the number of days a patient is alive and at home in the first 30 days after treatment.
It combines survival, time in hospital, and recovery into a single, patient-centred outcome.
Most medical outcomes focus on technical success or complications.
But for patients, an important question is often:
“How quickly will I get home and recover?”
DAH30 answers this directly.
It reflects:
DAH30 aligns clinical outcomes with what matters most to patients: time at home.
DAH30 is already used in surgery and healthcare systems and is designed for real-world data and clinical registries.
DAH30 = Number of days alive and at home within 30 days after treatment
Start with 30 days, then subtract:
DAH30 = 30 − (hospital days + rehab days + unplanned readmission days)
Example 1 (Straightforward recovery)
Example 2 (Complication + readmission)
Example 3 (Planned second procedure)
Use the following formatted excel sheet and practice running through this rmarkdown document.
minimum_dataset.xlsx
workbook_minimum.Rmd
The code should create the following output file in your working directory with calculated DAH30 scores.
30days.xlsx
If the above steps work for you, you can try editing the minimum_dataset to include your own data with the same formatting.
For interrogatability, the output 30days.xlsx will show you which date intervals have been subtracted from the 30 post-op days under the column “merged_intervals”, as well as counts for those days under “overlap_days”.
DAH30 has been evaluated in 614 unruptured brain aneurysm treatments at a major neurovascular centre in Melbourne (Monash Health).
Overall, DAH30 provides a simple and reliable way to measure real-world recovery after unruptured brain aneurysm treatment.
Chandra RV, Taylor F, Gall S, et al.
30-day home time as a patient-centered outcome after treatment of unruptured intracranial aneurysms
J NeuroInterventional Surgery, 2026
https://doi.org/10.1136/jnis-2025-024914
For patients
For clinicians
For researchers and systems